Table 5.
Clinicopathological data | Overall Survival Time HR (95% CI) |
---|---|
Cyto-Only percentage | 0.966 *** (0.947, 0.985) |
Total Cyto percentage | 1.033 *** (1.011, 1.054) |
Nuc | 0.211 *** (0.052, 0.848) |
Luminal B | 0.488 (0.186, 1.284) |
Her2 positive | 0.839 (0.330, 2.135) |
Basal | 1.912 *** (1.038, 3.522) |
NPI- 2 | 0.676 (0.079, 5.794) |
NPI- 3 | 0.702 (0.081, 6.107) |
NPI- 4 | 1.516 (0.159, 14.442) |
Tumour size (mm) | 0.992 (0.974, 1.010) |
Stage II | 1.367 (0.543, 3.442) |
Stage III | 2.737 (0.809, 9.262) |
Age | 0.994 (0.961, 1.028) |
Menopause (post) | 1.560 (0.635, 3.832) |
n = 174 |
*p < 0.1; **p < 0.05; ***p < 0.01.